Multimodal imaging in rats reveals impaired neurovascular coupling in sustained hypertension

Stroke

Volumn 44, Issue 7, 2013, Pages 1957-1964

  Calcinaghi, Novella ^a,b   Wyss, Matthias T ^a,b   Jolivet, Renaud ^a,b   Singh, Anand ^a,b   Keller, Anna L ^c   Winnik, Stephan ^a,c   Fritschy, Jean Marc ^a,b   Buck, Alfred ^a,b,c,d   Matter, Christian M ^a,c   Weber, Bruno ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

cerebrovascular circulation; hypertension; multimodality imaging; neurovascular coupling; spontaneously hypertensive rats

Indexed keywords

LOSARTAN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTERY ENDOTHELIUM; ARTICLE; BRAIN BLOOD FLOW; CELL LYSATE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ERYTHROCYTE; FUNCTIONAL ASSESSMENT; HEMODYNAMICS; HISTOPATHOLOGY; HOMEOSTASIS; HYPEREMIA; HYPERTENSION; LASER; MALE; MICROVASCULAR ISCHEMIA; MULTIPHOTON MICROSCOPY; NEUROIMAGING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRUCTURE ANALYSIS;

CEREBROVASCULAR CIRCULATION; HYPERTENSION; MULTIMODALITY IMAGING; NEUROVASCULAR COUPLING; SPONTANEOUSLY HYPERTENSIVE RATS;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; HYPERTENSION; LOSARTAN; MALE; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SPECTROMETRY, X-RAY EMISSION; VERAPAMIL;

EID: 84879952423     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000185     Document Type: Article

References (51)

1. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518
2. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: A guideline from the american heart association/american stroke association stroke council: Cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group: The american academy of neurology affirms the value of this guideline. Stroke. 2006;37:1583-1633
3. Dahlf B. Prevention of stroke in patients with hypertension. Am J Cardiol 2007;100(3A):17J-24J
4. Wei L, Lin SZ, Tajima A, Nakata H, Acuff V, Patlak C, et al. Cerebral glucose utilization and blood flow in adult spontaneously hypertensive rats. Hypertension. 1992;20:501-510
5. Leoni RF, Paiva FF, Henning EC, Nascimento GC, Tanns A, de Araujo DB, et al. Magnetic resonance imaging quantification of regional cerebral blood flow and cerebrovascular reactivity to carbon dioxide in normotensive and hypertensive rats. Neuroimage. 2011;58:75-81
6. Katsuta T. Decreased local cerebral blood flow in young and aged spontaneously hypertensive rats. Fukuoka Igaku Zasshi. 1997;88:65-74
7. Heinert G, Casadei B, Paterson DJ. Hypercapnic cerebral blood flow in spontaneously hypertensive rats. J Hypertens. 1998;16:1491-1498
8. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res. 2004;95:1019-1026
9. Capone C, Faraco G, Anrather J, Zhou P, Iadecola C. Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension. 2010;55:911-917
10. Iadecola C, Capone C, Faraco G, Park L, Cao XA, Davisson RL. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin ii precedes the development of hypertension. Am J Physiol-Heart Circ Physiol. 2011;300:H397-H407
11. Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, et al. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology 2005;64:1358-1365
12. Bentourkia M, Bol A, Ivanoiu A, Labar D, Sibomana M, Coppens A, et al. Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging. J Neurol Sci. 2000;181:19-28
13. Ances BM, Liang CL, Leontiev O, Perthen JE, Fleisher AS, Lansing AE, et al. Effects of aging on cerebral blood flow, oxygen metabolism, and blood oxygenation level dependent responses to visual stimulation. Hum Brain Mapp. 2009;30:1120-1132
14. Dubeau S, Ferland G, Gaudreau P, Beaumont E, Lesage F. Cerebrovascular hemodynamic correlates of aging in the Lou/c rat: a model of healthy aging. Neuroimage. 2011;56:1892-1901
15. Calcinaghi N, Jolivet R, Wyss MT, Ametamey SM, Gasparini F, Buck A, et al. Metabotropic glutamate receptor mGluR5 is not involved in the early hemodynamic response. J Cereb Blood Flow Metab. 2011;31:e1-10
16. Kleinfeld D, Mitra PP, Helmchen F, Denk W. Fluctuations and stimulus- induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc Natl Acad Sci USA. 1998;95:15741-15746
17. Haiss F, Jolivet R, Wyss MT, Reichold J, Braham NB, Scheffold F, et al. Improved in vivo two-photon imaging after blood replacement by perfluorocarbon. J Physiol. 2009;587(Pt 13):3153-3158
18. Fortepiani LA, Rodrigo E, Ortz MC, Cachofeiro V, Atucha NM, Ruilope LM, et al. Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatments. J Am Soc Nephrol. 1999;10:21-27
19. Gohlke P, Linz W, Schlkens BA, Wiemer G, Unger T. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension. 1996;28:397-402
20. Drew PJ, Blinder P, Cauwenberghs G, Shih AY, Kleinfeld D. Rapid determination of particle velocity from space-time images using the Radon transform. J Comput Neurosci. 2010;29:5-11
21. Weber B, Keller AL, Reichold J, Logothetis NK. The microvascular system of the striate and extrastriate visual cortex of the macaque. Cereb Cortex. 2008;18:2318-2330
22. Amenta F, Antonietta M, Tullio D, Tomassoni D. Arterial hypertension and brain damage-evidence from animal models (review). Clin Exp Hyperts. 2003;25:359-380
23. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev 2011;91:461-553
24. Imai Y, Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia. 2002;40:164-174
25. Sacco RL. Newer risk factors for stroke. Neurology. 2001;57(5 Suppl 2):S31-S34
26. Claassen JA, van Beek AH, Rikkert MG, Jansen RW. Cerebral autoregulation: An overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28:1071-1085
27. Baumbach GL, Heistad DD. Adaptive changes in cerebral blood vessels during chronic hypertension. J Hypertens 1991;9:987-991
28. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke. 2007;38:1766-1773
29. Franceschini MA, Radhakrishnan H, Thakur K, Wu W, Ruvinskaya S, Carp S, et al. The effect of different anesthetics on neurovascular coupling. Neuroimage. 2010;51:1367-1377
30. Aanerud J, Borghammer P, Chakravarty MM, Vang K, Rodell AB, Jnsdottir KY, et al. Brain energy metabolism and blood flow differences in healthy aging. J Cereb Blood Flow Metab. 2012;32:1177-1187
31. Yao H, Ooboshi H, Ibayashi S, Uchimura H, FujishiMarano M.A. Cerebral blood flow and ischemia-induced neurotransmitter release in the striatum of aged spontaneously hypertensive rats. Stroke. 1993;24:577-580
32. Park L, Anrather J, Girouard H, Zhou P, Iadecola C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab. 2007;27:1908-1918
33. Ohta K, Gotoh F, Shimazu K, Amano T, Komatsumoto S, Hamada J, et al. Locus coeruleus stimulation exerts different influences on the dynamic changes of cerebral pial and intraparenchymal vessels. Neurol Res. 1991;13:164-167
34. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2:161-192
35. Sabino B, Lessa MA, Nascimento AR, Rodrigues CA, Henriques Md, Garzoni LR, et al. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis. J Cardiovasc Pharmacol. 2008;51:402-409
36. Vaja V, Ochodnicky P, Krenek P, Klimas J, Bajuszova Z, Kyselovic J. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Eur J Pharmacol. 2009;619:85-91
37. Dupuis F, Vincent JM, Limiana P, Chillon JM, Capdeville-Atkinson C, Atkinson J. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat. J Hypertens. 2010;28:1566-1573
38. Chrissobolis S, Faraci FM. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med. 2008;14:495-502
39. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler Thromb Vasc Biol. 2007;27:303-309
40. Capone C, Faraco G, Peterson JR, Coleman C, Anrather J, Milner TA, et al. Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. J Neurosci. 2012;32:4878-4886
41. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals. Arterioscler Thromb Vasc Biol. 2006;26:826-832
42. Paravicini TM, Chrissobolis S, Drummond GR, Sobey CG. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke. 2004;35:584-589
43. Wang D, Chabrashvili T, Wilcox CS. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res. 2004;94:1436-1442
44. Weber DS, Rocic P, Mellis AM, Laude K, Lyle AN, Harrison DG, et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2005;288:H37-H42
45. Faraci FM. Protecting the brain with eNOS: run for your life. Circ Res. 2006;99:1029-1030
46. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009;61:62-97
47. Hojn S, Kadlecov M, Dobesov Z, Valouskov V, Zicha J, Kunes J. The participation of brain NO synthase in blood pressure control of adult spontaneously hypertensive rats. Mol Cell Biochem. 2007;297:21-29
48. van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192:1731-1744
49. Lin SZ, Sposito N, Pettersen S, Rybacki L, McKenna E, Pettigrew K, et al. Cerebral capillary bed structure of normotensive and chronically hypertensive rats. Microvasc Res. 1990;40:341-357
50. Struijker Boudier HA, le Noble JL, Messing MW, Huijberts MS, le Noble FA, van Essen H. The microcirculation and hypertension. J Hypertens Suppl. 1992;10:S147-S156
51. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008;7:476-484.